Skip to content

Value of Trans-Impedance Matrix (TIM) measurement for detection of New Bone Formation (NBF) and influence on electrophysiology, residual hearing and performance.

Value of Trans-Impedance Matrix (TIM) measurement for detection of New Bone Formation (NBF) and influence on electrophysiology, residual hearing and performance. - TIM measurement for detecting NBF

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON48046
Enrollment
30
Registered
2019-08-27
Start date
2019-11-06
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

New Bone Formation severe-to-profound hearing loss

Interventions

None listed

Sponsors

Radboud Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: All patients selected for cochlear implatation willing to participate (signed informed consent for study protocol)

Exclusion criteria

Exclusion criteria: Patients unable to have a CT-scan Patients with any anatomical situation influencing normal insertion

Design outcomes

Primary

MeasureTime frame
- Confirmation that NBF can reliably be detected using UHR CT-scan - Confirmation the TIM measurement is useful to detect and monitor NBF

Secondary

MeasureTime frame
- Investigate co-registered changes of C-/T-levels in relation with NBF growth - Confirm the influence of NBF on long term residual hearing - Investigate electrode position and correlate with study outcomes - Evaluate changes in performance over time possibly associated with NBF

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)